4850 West 78th Street
Indianapolis
, IN
, IN
News
-
Point Biopharma Inc soared 84% to $12.23 after the company agreed to be acquired by Eli Lilly for $12.50 a share in cash or $1.4 billion.
Eli Lilly & Company decreased 1.1% to $532.39.
Oct 3, 2023
Executive/
Director
Links
Price
- Last Close
-
$ 12.5
$ +0.02 0.16 %
Dec 26, 2023
- 52-Week High/Low
- $14.23 - $6.67
- YTD
- 0%
- Trading Volume
- 3,290,996
- Market Cap Full
- $
- Shares Outstanding
-
Jan 1, 1970
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | - | -24.7% | 42.3% | -0.3% | - | - |
| Q2 | - | - | - | - | - | -2.2% | -14.6% | 24.6% | - | - |
| Q3 | - | - | - | - | 17.5% | -25.2% | 13.5% | -26.4% | - | - |
| Q4 | - | - | - | - | -3% | -27.2% | -5.7% | 87% | - | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | 0% | 0% | -60% | 30% | 71% | 0% | 0% |
Earnings
| Q1 |
| Q2 |
| Q3 |
| Q4 |
| A |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
| Mar |
| Jun |
| Sep |
| Dec |
Annual
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Asset Management | |||||
| Inventory / Stock Turnover | - | - | - | - | - |
| Total Asset Turnover | 0.4 | - | - | - | - |
| Fixed Asset Turnover | 4.8 | - | - | - | - |
| Leverage | |||||
| Debt Ratio | - | - | - | - | - |
| Debt – Equity Ratio | - | - | - | - | - |
| Interest Coverage | 4.5 | - | - | - | - |
| Equity multiplier | 0.1 | 0.1 | 0.8 | - | - |